Translational Research on Angiogenesis and Related Disorders

Dear Colleagues,

Angiogenesis is a complex biological process that involves the formation of new blood vessels from existing ones, which is crucial for normal development and wound healing. Pathological angiogenesis, however, contributes to many diseases, particularly cardiovascular diseases (such as atherosclerosis, stroke, pulmonary hypertension, and cardiac hypertrophy), cancer, diabetic retinopathy, and diabetic delayed wound healing. Understanding the role of angiogenesis in these disorders is essential for developing targeted therapies and improving patient outcomes.

While extensive research has been conducted on angiogenesis, this Special Issue aims to focus specifically on the translational aspects of angiogenesis research. We aim to provide a comprehensive understanding of angiogenesis and its relevance to specific disorders, in order to facilitate the development of targeted therapies, diagnostic tools, and treatment interventions that can improve patient outcomes.

We welcome your contributions in the form of original research and review articles on aspects including, but not limited to, the following:

• Therapeutic Target Identification: Identifying and understanding the molecular mechanisms that regulate angiogenesis in related disorders.
• Biomarker Discovery: Identifying biomarkers that can be used to diagnose, prognose, and monitor angiogenesis and related disorders.
• Drug Development and Preclinical Studies: Development and testing of novel or classical/clinical drugs and therapies targeting angiogenesis in related disorders.
• Clinical Implementation: Conducting clinical trials, optimizing treatment protocols, and developing guidelines for the management of angiogenesis and related disorders.

Dr. Jian Li
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• angiogenesis
• cardiovascular diseases
• cancers
• diabetic complications
• therapeutic target
• biomarkers
• drug development
• clinical implementation